Average Co-Inventor Count = 7.76
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Arena Pharmaceuticals, Inc. (29 from 216 patents)
2. Boehringer Ingelheim International Gmbh (2 from 1,535 patents)
3. Pipeline Therapeutics, Inc. (2 from 4 patents)
4. Aries Associates, Inc. (2 from 2 patents)
5. Contineum Therapeutics, Inc. (2 from 2 patents)
6. Arena Pharmeceuticals, Inc. (1 from 1 patent)
36 patents:
1. 12390462 - Muscarinic acetylcholine M1 receptor antagonists
2. 12115157 - 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicament
3. 12109219 - Cannabinoid receptor modulators
4. 12054487 - Muscarinic acetylcholine Mreceptor antagonists
5. 11780827 - Substituted 3-phenoxyazetidin-1-yl-pyrazines
6. 11771695 - Cannabinoid receptor modulators
7. 11752149 - Muscarinic acetylcholine M1 receptor antagonists
8. 11746091 - Cannabinoid receptor modulators
9. 11512090 - Muscarinic acetylcholine Mreceptor antagonists
10. 11214548 - Cannabinoid receptor modulators
11. 10781180 - 3-phenyl-pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto
12. 10632134 - Cannabinoid receptor modulators
13. 10351531 - [object Object]
14. 10058549 - [object Object]
15. 9944606 - Cannabinoid receptor modulators